Results
76
Companies which have announced upcoming dividend payments.
76 companies
Tyche Industries
Market Cap: ₹1.4b
Manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally.
532384
₹137.10
7D
-3.7%
1Y
-26.9%
Kaken Pharmaceutical
Market Cap: JP¥144.8b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,823.00
7D
-0.6%
1Y
-4.6%
Otsuka Holdings
Market Cap: JP¥4.2t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥8,000.00
7D
-2.2%
1Y
-3.0%
Vita Life Sciences
Market Cap: AU$136.3m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$2.44
7D
-4.7%
1Y
13.0%
Jagsonpal Pharmaceuticals
Market Cap: ₹15.7b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹234.91
7D
-3.5%
1Y
41.5%
Takeda Pharmaceutical
Market Cap: JP¥6.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,441.00
7D
-0.2%
1Y
4.6%
Merck
Market Cap: US$199.0b
Operates as a healthcare company worldwide.
MRK
US$77.60
7D
-4.8%
1Y
-31.4%
Santen Pharmaceutical
Market Cap: JP¥536.5b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,640.50
7D
-0.6%
1Y
-10.3%
Astellas Pharma
Market Cap: JP¥3.0t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,661.50
7D
0.7%
1Y
-3.3%
Nippon Shinyaku
Market Cap: JP¥223.0b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,309.00
7D
-0.03%
1Y
-15.3%
Ono Pharmaceutical
Market Cap: JP¥801.7b
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,706.50
7D
-0.8%
1Y
-13.9%
Bristol-Myers Squibb
Market Cap: US$89.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
US$43.41
7D
-4.8%
1Y
-13.4%
Shionogi
Market Cap: JP¥2.2t
Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.
4507
JP¥2,612.50
7D
-1.4%
1Y
21.0%
Tsumura
Market Cap: JP¥274.6b
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.
4540
JP¥3,676.00
7D
-3.0%
1Y
-18.7%
Fuji Pharma
Market Cap: JP¥38.3b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,570.00
7D
1.7%
1Y
19.6%
Gilead Sciences
Market Cap: US$141.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.99
7D
-2.3%
1Y
33.7%
Caplin Point Laboratories
Market Cap: ₹165.7b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,180.35
7D
-6.0%
1Y
13.5%
Lincoln Pharmaceuticals
Market Cap: ₹10.9b
Engages in manufacturing and trading of pharmaceutical products in India.
531633
₹543.45
7D
-1.8%
1Y
-20.8%
Zeria Pharmaceutical
Market Cap: JP¥92.2b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,092.00
7D
-0.6%
1Y
-7.6%
Panchsheel Organics
Market Cap: ₹1.8b
Engages in the manufacture and trading of bulk drugs and intermediates in India and internationally.
531726
₹138.60
7D
-3.0%
1Y
-40.9%
Sawai Group Holdings
Market Cap: JP¥232.7b
Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.
4887
JP¥2,016.00
7D
-1.0%
1Y
-5.8%
Eisai
Market Cap: JP¥1.5t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥5,154.00
7D
-0.2%
1Y
-7.2%
Kissei Pharmaceutical
Market Cap: JP¥184.4b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥4,450.00
7D
1.0%
1Y
23.1%
Jubilant Pharmova
Market Cap: ₹169.8b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹1,071.80
7D
-3.9%
1Y
-9.1%
Orion Oyj
Market Cap: €9.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€65.00
7D
-0.9%
1Y
31.2%
AbbVie
Market Cap: US$388.6b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$218.54
7D
-1.6%
1Y
13.9%
Kyowa Kirin
Market Cap: JP¥1.2t
Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.
4151
JP¥2,310.50
7D
-3.7%
1Y
-11.6%
Hisamitsu Pharmaceutical
Market Cap: JP¥297.7b
Manufactures and sells pharmaceuticals in Japan.
4530
JP¥4,185.00
7D
-0.5%
1Y
4.3%
CSL
Market Cap: AU$95.8b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$197.99
7D
-0.2%
1Y
-32.0%
Agilent Technologies
Market Cap: US$35.3b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$121.89
7D
-4.5%
1Y
-16.9%
KYORIN Pharmaceutical
Market Cap: JP¥87.3b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,519.00
7D
-0.7%
1Y
-2.8%
SSY Group
Market Cap: HK$8.7b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.96
7D
-1.7%
1Y
-24.3%
CSPC Pharmaceutical Group
Market Cap: HK$106.3b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.30
7D
-8.3%
1Y
70.3%
Daito PharmaceuticalLtd
Market Cap: JP¥37.4b
Manufactures and sells pharmaceutical products worldwide.
4577
JP¥1,247.00
7D
3.7%
1Y
6.4%
ASKA Pharmaceutical HoldingsLtd
Market Cap: JP¥67.7b
Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.
4886
JP¥2,386.00
7D
-0.1%
1Y
6.9%
China Shineway Pharmaceutical Group
Market Cap: HK$6.1b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.14
7D
-3.6%
1Y
-5.0%